Why Did Ken Griffin Buy Sweetgreen Stock?
In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…
Sell
46
ADGM Quote, Financials, Valuation and Earnings
Last price:
$1.22
Seasonality move
:
-13.19%
Day range:
$1.20 - $1.28
52-week range:
$0.63 - $11.57
Dividend yield:
0%
P/E ratio:
218.00x
P/S ratio:
85.03x
P/B ratio:
1.53x
Volume:
60.5K
Avg. volume:
84.1K
1-year change:
-89.26%
Market cap:
$18.9M
Revenue:
--
EPS (TTM):
-$0.27
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings
|
-- | -- | -- | -- | -- |
|
AIMD
Ainos
|
-- | -- | -- | -- | -- |
|
INBS
Intelligent Bio Solutions
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools
|
$40.1M | -$0.04 | 7.07% | -66.67% | $2.38 |
|
LNSR
LENSAR
|
$13.4M | -$0.16 | 30.98% | -90.51% | $15.00 |
|
MOVE
Movano
|
$3.9M | -$0.70 | 76.06% | -41.21% | $30.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings
|
$1.23 | -- | $18.9M | 218.00x | $0.00 | 0% | 85.03x |
|
AIMD
Ainos
|
$0.56 | -- | $11.5M | -- | $0.00 | 0% | 56.59x |
|
INBS
Intelligent Bio Solutions
|
$1.98 | -- | $13.7M | -- | $0.00 | 0% | 2.96x |
|
LAB
Standard BioTools
|
$1.08 | $2.38 | $390.1M | -- | $0.00 | 0% | 2.38x |
|
LNSR
LENSAR
|
$12.96 | $15.00 | $152.8M | -- | $0.00 | 0% | 2.64x |
|
MOVE
Movano
|
$0.79 | $30.00 | $5.5M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings
|
-- | 0.405 | -- | -- |
|
AIMD
Ainos
|
47.77% | 2.165 | 141.91% | 1.73x |
|
INBS
Intelligent Bio Solutions
|
6.51% | 3.270 | 3.7% | 0.84x |
|
LAB
Standard BioTools
|
0.07% | -0.784 | 0.07% | 5.22x |
|
LNSR
LENSAR
|
-- | -0.430 | -- | 1.20x |
|
MOVE
Movano
|
-- | 5.208 | -- | 2.72x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings
|
-$253K | -$7.4M | -- | -- | -- | -$7.5M |
|
AIMD
Ainos
|
$88K | -$3.2M | -50.84% | -82.37% | -2924.08% | -$1.3M |
|
INBS
Intelligent Bio Solutions
|
$341.4K | -$2.6M | -140.31% | -149.7% | -347.89% | -$2.8M |
|
LAB
Standard BioTools
|
$19.7M | -$30.3M | -24.87% | -26.52% | -64.18% | -$35.3M |
|
LNSR
LENSAR
|
$7.1M | -$5.8M | -464.33% | -464.33% | -40.89% | -$6.9M |
|
MOVE
Movano
|
-$795K | -$7.4M | -- | -- | -14758% | -$5.7M |
Adagio Medical Holdings vs. Competitors
-
Which has Higher Returns ADGM or AIMD?
Ainos has a net margin of -- compared to Adagio Medical Holdings's net margin of -3093.98%. Adagio Medical Holdings's return on equity of -- beat Ainos's return on equity of -82.37%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.51 -- AIMDAinos82.83% -$0.21 $25.1M -
What do Analysts Say About ADGM or AIMD?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Ainos has an analysts' consensus of -- which suggests that it could fall by --. Given that Adagio Medical Holdings has higher upside potential than Ainos, analysts believe Adagio Medical Holdings is more attractive than Ainos.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 AIMDAinos0 0 0 -
Is ADGM or AIMD More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ainos has a beta of 2.202, suggesting its more volatile than the S&P 500 by 120.24%.
-
Which is a Better Dividend Stock ADGM or AIMD?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ainos offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Ainos pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or AIMD?
Adagio Medical Holdings quarterly revenues are --, which are smaller than Ainos quarterly revenues of $106.2K. Adagio Medical Holdings's net income of -$7.7M is lower than Ainos's net income of -$3.3M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while Ainos's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 85.03x versus 56.59x for Ainos. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings85.03x 218.00x -- -$7.7M AIMDAinos56.59x -- $106.2K -$3.3M
-
Which has Higher Returns ADGM or INBS?
Intelligent Bio Solutions has a net margin of -- compared to Adagio Medical Holdings's net margin of -348.97%. Adagio Medical Holdings's return on equity of -- beat Intelligent Bio Solutions's return on equity of -149.7%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.51 -- INBSIntelligent Bio Solutions46.84% -$0.44 $5.3M -
What do Analysts Say About ADGM or INBS?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Intelligent Bio Solutions has an analysts' consensus of -- which suggests that it could grow by 506.06%. Given that Intelligent Bio Solutions has higher upside potential than Adagio Medical Holdings, analysts believe Intelligent Bio Solutions is more attractive than Adagio Medical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 INBSIntelligent Bio Solutions0 0 0 -
Is ADGM or INBS More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intelligent Bio Solutions has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ADGM or INBS?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Intelligent Bio Solutions pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or INBS?
Adagio Medical Holdings quarterly revenues are --, which are smaller than Intelligent Bio Solutions quarterly revenues of $728.9K. Adagio Medical Holdings's net income of -$7.7M is lower than Intelligent Bio Solutions's net income of -$2.5M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while Intelligent Bio Solutions's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 85.03x versus 2.96x for Intelligent Bio Solutions. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings85.03x 218.00x -- -$7.7M INBSIntelligent Bio Solutions2.96x -- $728.9K -$2.5M
-
Which has Higher Returns ADGM or LAB?
Standard BioTools has a net margin of -- compared to Adagio Medical Holdings's net margin of -63.81%. Adagio Medical Holdings's return on equity of -- beat Standard BioTools's return on equity of -26.52%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.51 -- LABStandard BioTools48.39% -$0.07 $454.9M -
What do Analysts Say About ADGM or LAB?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Standard BioTools has an analysts' consensus of $2.38 which suggests that it could grow by 119.91%. Given that Standard BioTools has higher upside potential than Adagio Medical Holdings, analysts believe Standard BioTools is more attractive than Adagio Medical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 LABStandard BioTools2 1 0 -
Is ADGM or LAB More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools has a beta of 1.500, suggesting its more volatile than the S&P 500 by 50.042%.
-
Which is a Better Dividend Stock ADGM or LAB?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Standard BioTools pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or LAB?
Adagio Medical Holdings quarterly revenues are --, which are smaller than Standard BioTools quarterly revenues of $40.8M. Adagio Medical Holdings's net income of -$7.7M is higher than Standard BioTools's net income of -$26M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while Standard BioTools's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 85.03x versus 2.38x for Standard BioTools. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings85.03x 218.00x -- -$7.7M LABStandard BioTools2.38x -- $40.8M -$26M
-
Which has Higher Returns ADGM or LNSR?
LENSAR has a net margin of -- compared to Adagio Medical Holdings's net margin of -193.13%. Adagio Medical Holdings's return on equity of -- beat LENSAR's return on equity of -464.33%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.51 -- LNSRLENSAR50.32% -$2.32 -$22.1M -
What do Analysts Say About ADGM or LNSR?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand LENSAR has an analysts' consensus of $15.00 which suggests that it could grow by 15.74%. Given that LENSAR has higher upside potential than Adagio Medical Holdings, analysts believe LENSAR is more attractive than Adagio Medical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 LNSRLENSAR0 2 0 -
Is ADGM or LNSR More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ADGM or LNSR?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. LENSAR pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or LNSR?
Adagio Medical Holdings quarterly revenues are --, which are smaller than LENSAR quarterly revenues of $14.2M. Adagio Medical Holdings's net income of -$7.7M is higher than LENSAR's net income of -$27.3M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while LENSAR's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 85.03x versus 2.64x for LENSAR. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings85.03x 218.00x -- -$7.7M LNSRLENSAR2.64x -- $14.2M -$27.3M
-
Which has Higher Returns ADGM or MOVE?
Movano has a net margin of -- compared to Adagio Medical Holdings's net margin of -14402%. Adagio Medical Holdings's return on equity of -- beat Movano's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.51 -- MOVEMovano-1590% -$1.06 $10.3M -
What do Analysts Say About ADGM or MOVE?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Movano has an analysts' consensus of $30.00 which suggests that it could grow by 3718.25%. Given that Movano has higher upside potential than Adagio Medical Holdings, analysts believe Movano is more attractive than Adagio Medical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 MOVEMovano0 0 0 -
Is ADGM or MOVE More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Movano has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ADGM or MOVE?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Movano offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Movano pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or MOVE?
Adagio Medical Holdings quarterly revenues are --, which are smaller than Movano quarterly revenues of $50K. Adagio Medical Holdings's net income of -$7.7M is lower than Movano's net income of -$7.2M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while Movano's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 85.03x versus -- for Movano. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings85.03x 218.00x -- -$7.7M MOVEMovano-- -- $50K -$7.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Planet Labs’ Stock Go Next?
On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…
Where Will VICI Properties Be in 5 Years?
VICI Properties (NYSE:VICI) is a real estate investment trust focused…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
73
OKLO alert for Jun 12
Oklo [OKLO] is down 1.96% over the past day.
Buy
87
SMR alert for Jun 12
NuScale Power [SMR] is up 1.01% over the past day.
Buy
53
PLAY alert for Jun 12
Dave & Buster's Entertainment [PLAY] is up 1.02% over the past day.
